title: Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects.
abstract: OBJECTIVE
  To compare the risk of cardiovascular disease (CVD) death and the impact of hyperglycemia on the risk of CVD mortality associated with type 1 diabetes to that associated with type 2 diabetes.
  
  
  METHODS
  The study comprised 173 participants with type 1 diabetes, 834 participants with type 2 diabetes, and 1,294 nondiabetic participants, aged 45-64 years at baseline and free of CVD. The age of onset of diabetes was >30 years in both diabetic groups.
  
  
  RESULTS
  During an 18-year follow-up, 86 participants with type 1 diabetes, 567 participants with type 2 diabetes, and 252 nondiabetic participants died. CVD mortality rates per 1,000 person-years were 23.1 (95% CI 16.9-31.9) in type 1 diabetic, 35.3 (30.8-40.4) in type 2 diabetic, and 4.6 (3.8-5.7) in nondiabetic participants. Adjusted hazard ratios for CVD mortality in participants with type 1 diabetes versus no diabetes was 3.6 (95% CI 2.2-5.7) in men and 13.3 (6.9-22.5) in women and in participants with type 2 diabetes versus no diabetes 3.3 (2.5-4.5) in men and 10.1 (6.7-17.4) in women. An increment of 1 unit (%) of GHb increased CVD mortality by 52.5% (95% CI 28.4-81.3) in type 1 diabetic subjects and by 7.5% (4.3-10.8) in type 2 diabetic participants.
  
  
  CONCLUSIONS
  The impact of type 1 and type 2 diabetes on CVD mortality was similar. The effect of increasing hyperglycemia on the risk of CVD mortality was more profound in type 1 than in type 2 diabetic subjects.
authors: Kuopio University Hospital, Kuopio, Finland.
authors: Auni
authors: A
authors: Juutilainen
authors: Seppo
authors: S
authors: Lehto
authors: Tapani
authors: T
authors: Rönnemaa
authors: Kalevi
authors: K
authors: Pyörälä
authors: Markku
authors: M
authors: Laakso
mesh_terms: D001794:Blood Pressure; D002318:Cardiovascular Diseases / Q000401:mortality*; D008076:Cholesterol, HDL / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000401:mortality / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000401:mortality / Q000503:physiopathology; D003925:Diabetic Angiopathies / Q000401:mortality*; D005260:Female; D005387:Finland / Q000453:epidemiology; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D016016:Proportional Hazards Models; D012727:Sex Characteristics
chemical_list: D008076:Cholesterol, HDL; D006442:Glycated Hemoglobin